Harvard Bioscience
HBIO
#8788
Rank
NZ$0.16 B
Marketcap
$3.87
Share price
5.09%
Change (1 day)
-49.50%
Change (1 year)

Harvard Bioscience (HBIO) - Total debt

Total debt on the balance sheet as of June 2024 : NZ$70.7 Million

According to Harvard Bioscience's latest financial reports the company's total debt is NZ$70.7 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Harvard Bioscience - Total debt on balance sheet (from 2000 to 2024)

Total debt by year

Year Total debt Change
2023-12-31NZ$67.63 M-20.83%
2022-12-31NZ$85.43 M2.45%
2021-12-31NZ$83.39 M4.46%
2020-12-31NZ$79.82 M-16.6%
2019-12-31NZ$95.71 M5.61%
2018-12-31NZ$90.63 M447.91%
2017-12-31NZ$16.54 M-16.64%
2016-12-31NZ$19.84 M-27.5%
2015-12-31NZ$27.37 M-0.02%
2014-12-31NZ$27.37 M-9.1%
2013-12-31NZ$30.11 M91.32%
2012-12-31NZ$15.74 M-24.63%
2011-12-31NZ$20.88 M-10.55%
2010-12-31NZ$23.34 M27.31%
2009-12-31NZ$18.34 M649.52%
2008-12-31NZ$2.44 M-75.81%
2007-12-31NZ$10.11 M137.5%
2006-12-31NZ$4.25 M-65.84%
2005-12-31NZ$12.46 M-46.22%
2004-12-31NZ$23.17 M14.28%
2003-12-31NZ$20.28 M865.89%
2002-12-31NZ$2.09 M-80.76%
2001-12-31NZ$10.91 M62007.49%
2000-12-31NZ$0.01 M-99.89%
1999-12-31NZ$15.43 M